Skip to content

Incyte INCY Business Segments

FY'25FY'24FY'23FY'22
Total revenues by Product
ICLUSIG$134.07M+17.3%$114.32M+2.4%$111.62M+5.5%$105.84M-3.3%
JAKAFI$3.09B+10.8%$2.79B+7.6%$2.59B+7.7%$2.41B+12.9%
JAKAVI Royalty Revenues$457.73M+9.3%$418.84M+13.9%$367.58M+10.9%$331.58M-1.9%
Milestone and contract revenues$150M+249%$43M+514%$7M-95.8%$165M+73.7%
MINJUVI/MONJUVI$144.58M+21.3%$119.24M+222%$37.06M+88.5%$19.65M
NIKTIMVO$151.64M$0$0
OPZELURA$678.46M+33.5%$508.29M+50.4%$337.86M+162%$128.74M
Other product royalty revenues$7.88M+263%$2.17M+10.4%$1.97M
PEMAZYRE$86.73M+6.1%$81.75M-2.3%$83.64M+0.2%$83.45M+21.8%
TABRECTA Royalty Revenues$26.7M+17.4%$22.75M+27.8%$17.79M+15.5%$15.41M+48.3%
ZYNYZ$66.35M+1,983%$3.19M+155%$1.25M$0
Total revenues by Geography
Europe$323.73M+24.3%$260.41M+48.1%$175.87M+19.6%$147M+18.5%
Other countries$17.57M+182%$6.22M+26.7%$4.91M
United States$4.8B+20.8%$3.97B+13.1%$3.51B+9.8%$3.2B+10.3%
PP&E (Net) by Geography
Other countries$54.68M
Switzerland$1.21B
United States$1.83B

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How does Incyte break its business down?
Incyte (INCY) reports total revenues by product across 12 parts — ICLUSIG, JAKAFI, JAKAVI Royalty Revenues, Milestone and contract revenues and MINJUVI/MONJUVI. Each is extracted from the segment footnotes and tracked over time.
Where does Incyte's segment data come from?
Segment breakdowns are pulled from the segment footnotes in Incyte's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.